Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Jun 24:2:57.
doi: 10.1038/s41746-019-0130-0. eCollection 2019.

Machine learning detection of obstructive hypertrophic cardiomyopathy using a wearable biosensor

Affiliations

Machine learning detection of obstructive hypertrophic cardiomyopathy using a wearable biosensor

Eric M Green et al. NPJ Digit Med. .

Abstract

Hypertrophic cardiomyopathy (HCM) is a heritable disease of heart muscle that increases the risk for heart failure, stroke, and sudden death, even in asymptomatic patients. With only 10-20% of affected people currently diagnosed, there is an unmet need for an effective screening tool outside of the clinical setting. Photoplethysmography uses a noninvasive optical sensor incorporated in commercial smart watches to detect blood volume changes at the skin surface. In this study, we obtained photoplethysmography recordings and echocardiograms from 19 HCM patients with left ventricular outflow tract obstruction (oHCM) and a control cohort of 64 healthy volunteers. Automated analysis showed a significant difference in oHCM patients for 38/42 morphometric pulse wave features, including measures of systolic ejection time, rate of rise during systole, and respiratory variation. We developed a machine learning classifier that achieved a C-statistic for oHCM detection of 0.99 (95% CI: 0.99-1.0). With further development, this approach could provide a noninvasive and widely available screening tool for obstructive HCM.

Keywords: Diagnostic markers; Translational research.

PubMed Disclaimer

Conflict of interest statement

Competing interestsM.J.S. is an employee and owns shares in MyoKardia, Inc., a biotechnology company developing small molecules that target the sarcomere for the treatment of cardiomyopathies. R.vanM. and O.D. are employees and own shares in Wavelet Health. C.W. owns shares in MyoKardia, Inc. Support for these studies was provided by MyoKardia. The remaining authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Differences in photoplethysmography tracings between oHCM patients and healthy volunteers. a Single beats extracted from the PPG recordings and b 10 s continuous recordings illustrating differences in waveform morphology between two representative healthy subjects and two oHCM patients. Markers indicate separation between beats detected by an automated algorithm. Example morphometric features are shown as follows: (1) systolic ejection time, (2) slope of systolic rise, and (3) slope of diastolic decline. c Plot of the magnitude and statistical significance of the difference in feature values between healthy controls and oHCM patients for 42 analyzed pulse features. The 38 features with Bonferroni-corrected p < 0.05 are colored black and the remaining four are shown in red. d Receiver-operator curve with marker indicating the cutoff point used to derive the embedded confusion matrix

Comment in

Similar articles

Cited by

References

    1. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881–1891. doi: 10.1016/S0140-6736(04)16358-7. - DOI - PubMed
    1. Maron MS, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114:2232–2239. doi: 10.1161/CIRCULATIONAHA.106.644682. - DOI - PubMed
    1. Maron MS, et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. N. Engl. J. Med. 2003;348:295–303. doi: 10.1056/NEJMoa021332. - DOI - PubMed
    1. Braunwald E, Frank S. Idiopathic hypertrophic subaortic stenosis. Clinical analysis of 126 patients with emphasis on the natural history. Circulation. 1968;37:759–788. doi: 10.1161/01.CIR.37.5.759. - DOI - PubMed
    1. Maron BJ, et al. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785–789. doi: 10.1161/01.CIR.92.4.785. - DOI - PubMed